ArticleJournal of the science of food and agriculture2026
ACE-inhibitory peptide Leu-Tyr-Ala in skeletal muscle actin exhibits anti-aging effects through the inhibition of acn-1 in Caenorhabditis elegans.
Article in Journal of the science of food and agriculture, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundInhibitors of angiotensin-converting enzyme (ACE) are used in pharmaceuticals and functional foods. Captopril, a well-known ACE inhibitor, extends the lifespan of the nematode Caenorhabditis elegans. Bioactive peptides derived from food sources are considered safe ACE inhibitors. Previously, we identified the sequence Asp-Leu-Tyr-Ala in skeletal muscle actin and its derivatives, Leu-Tyr-Ala, Leu-Tyr, and Tyr-Ala, as antioxidant peptides. In the present study, we evaluated the ACE-inhibitory activity of peptides and their anti-aging effects in a C. elegans model.
resultsAmong the four peptides, Leu-Tyr-Ala showed the highest ACE-inhibitory activity in vitro. Leu-Tyr-Ala delayed the increase in body length and width in C. elegans but did not affect reproductive ability. The average lifespan of C. elegans treated with 5 mmol/L Leu-Tyr-Ala was 26% longer than that of the control group. The treatment of Leu-Tyr-Ala also improved locomotor activity, enhanced resistance to oxidative and thermal stress, reduced fat accumulation, and decreased lipofuscin levels in C. elegans. In addition, Leu-Tyr-Ala down-regulated the messenger RNA (mRNA) expression of acn-1 (a homolog of mammalian ACE in C. elegans) and up-regulated the mRNA expression of antioxidant (ctl-1, gst-4, mtl-1, and hsp-70), muscle-related (unc-54 and myo-3), and fat metabolism (daf-36, fat-5, and fat-7) via daf-12 and daf-16. Furthermore, a life-prolonging effect was not observed in daf-12 and daf-16 mutants, suggesting that Leu-Tyr-Ala may inhibit acn-1 function and exert anti-aging effects through daf-12 and daf-16.
conclusionOur findings provide evidence that ACE-inhibitory peptides can be used as functional food ingredients with anti-aging properties. © 2026 The Author(s). Journal of the Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.